Tandem (US Pharmaceutical Corporation)


Welcome to the PulseAid listing for the Tandem drug offered from US Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: US Pharmaceutical Corporation
NON-PROPRIETARY NAME: Ferrous Fumarate and Polysacchride Iron Complex
SUBSTANCE NAME: FERROUS FUMARATE; FERROUS ASPARTO GLYCINATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2006-02-17
END MARKETING DATE: 0000-00-00


Tandem HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTandem from US Pharmaceutical Corporation
LABELER NAME: US Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 162; 115.2(mg/1; mg/1)
START MARKETING DATE: 2006-02-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52747-900_6f3280b9-49e3-4ff2-9c07-80bd1fded4e4
PRODUCT NDC: 52747-900
APPLICATION NUMBER:

Other FERROUS FUMARATE; FERROUS ASPARTO GLYCINATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
US Pharmaceutical CorporationTandem